We are live on
!
Find out more
LC
Lindbrook Capital Portfolio holdings
AUM
$1.08B
1-Year Est. Return
10.14%
This Fund
S&P 500
This Quarter
Est. Return
+7.65%
1 Year Est. Return
+10.14%
3 Year Est. Return
+35.77%
5 Year Est. Return
+141.26%
10 Year Est. Return
–
AUM
$939M
AUM Growth
+$86.2M
(+10%)
Cap. Flow
+$29.6M
Cap. Flow
% of AUM
3.15%
Top 10 Holdings %
Top 10 Hldgs %
46.18%
Holding
2,925
New
150
Increased
988
Reduced
857
Closed
215
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Total International Stock ETF
VXUS
|
+$5.37M |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$3.7M |
| 3 |
Vanguard Morningstar Total Stock Market ETF
VTI
|
+$2.54M |
| 4 |
Invesco QQQ Trust
QQQ
|
+$2.12M |
| 5 |
NVIDIA
NVDA
|
+$1.88M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vertex Pharmaceuticals
VRTX
|
+$6.88M |
| 2 |
State Street Consumer Staples Select Sector SPDR ETF
XLP
|
+$4.62M |
| 3 |
Oaktree Specialty Lending
OCSL
|
+$825K |
| 4 |
MGI
MoneyGram International, Inc. New
MGI
|
+$627K |
| 5 |
ISEE
IVERIC bio, Inc. Common Stock
ISEE
|
+$562K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 16.18% |
| 2 | Technology | 15.3% |
| 3 | Healthcare | 6.27% |
| 4 | Consumer Discretionary | 3.61% |
| 5 | Industrials | 3.26% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2226
OneSpan
OSPN
$618M
| $1.63K | ﹤0.01% |
110
-80
| -42% | -$1.25K |
|
2227
Dillards
DDS
$9.56B
| $1.63K | ﹤0.01% |
5
| – | – |
|
2228
Mercury Systems
MRCY
$6.52B
| $1.63K | ﹤0.01% |
47
+14
| +42% | +$598 |
|
2229
Latham Group
SWIM
$880M
| $1.63K | ﹤0.01% |
+438
| New | +$1.34K |
|
|
BFS
2230
Saul Centers
BFS
$841M
| $1.62K | ﹤0.01% |
44
-1
| -2% | -$36 |
|
|
AVDL
2231
DELISTED
Avadel Pharmaceuticals
AVDL
| $1.61K | ﹤0.01% |
98
-2,000
| -95% | -$26K |
|
|
UCTT
2232
Ultra Clean Holdings
UCTT
$3.95B
| $1.61K | ﹤0.01% |
42
+12
| +40% | +$386 |
|
|
AKYA
2233
DELISTED
Akoya BioSciences
AKYA
| $1.6K | ﹤0.01% |
+217
| New | +$1.45K |
|
2234
Elastic
ESTC
$7.81B
| $1.6K | ﹤0.01% |
25
+13
| +108% | +$815 |
|
2235
Coherus Oncology
CHRS
$196M
| $1.6K | ﹤0.01% |
+375
| New | +$2.21K |
|
|
HPP
2236
Hudson Pacific Properties
HPP
$779M
| $1.59K | ﹤0.01% |
54
-458
| -89% | -$16.4K |
|
2237
Interface
TILE
$2.22B
| $1.59K | ﹤0.01% |
+181
| New | +$1.39K |
|
2238
VSE Corp
VSEC
$6.12B
| $1.59K | ﹤0.01% |
+29
| New | +$1.4K |
|
|
OPLN
2239
Openlane
OPLN
$4.54B
| $1.58K | ﹤0.01% |
104
| – | – |
|
2240
Blue Bird Corp
BLBD
$2.18B
| $1.57K | ﹤0.01% |
70
+50
| +250% | +$1.07K |
|
2241
Syndax Pharmaceuticals
SNDX
$1.82B
| $1.57K | ﹤0.01% |
75
-124
| -62% | -$2.58K |
|
2242
First Commonwealth Financial
FCF
$2.17B
| $1.57K | ﹤0.01% |
124
| – | – |
|
2243
Frontline
FRO
$8.85B
| $1.57K | ﹤0.01% |
108
| – | – |
|
2244
Viasat
VSAT
$11.1B
| $1.57K | ﹤0.01% |
38
+31
| +443% | +$1.21K |
|
2245
Minerals Technologies
MTX
$2.34B
| $1.56K | ﹤0.01% |
27
-4
| -13% | -$233 |
|
2246
Amneal Pharmaceuticals
AMRX
$5.79B
| $1.56K | ﹤0.01% |
+502
| New | +$1.07K |
|
|
VSXY
2247
Victoria's Secret
VSXY
$7.83B
| $1.55K | ﹤0.01% |
89
+35
| +65% | +$882 |
|
2248
Marten Transport
MRTN
$1.22B
| $1.55K | ﹤0.01% |
72
-111
| -61% | -$2.33K |
|
|
SIX
2249
DELISTED
Six Flags Entertainment Corp.
SIX
| $1.53K | ﹤0.01% |
59
-66
| -53% | -$1.71K |
|
|
AIFU
2250
AIFU Inc
AIFU
$221M
| – | – |
0
| – | – |
|
Similar funds
SBIA
CHP
MW
TAM
SIA
CIG
CCM
WCF
Lindbrook Capital's Q2 2023 Portfolio in Review
As of Q2 2023, Lindbrook Capital held 2,925 positions worth $939M, up 10% from $853M the previous quarter. Its ten largest holdings account for 46% of the portfolio.
Lindbrook Capital deployed $29.6M of net new capital in Q2 2023, opening 150 new positions and adding to 988 existing holdings. Its largest new stake was UPAR Ultra Risk Parity ETF: 21,000 shares worth $291K.
By sector, the portfolio is most concentrated in Financials at 16% of assets, down from 17% a quarter earlier, followed by Technology and Healthcare.
On the sell side, the largest reduction was Vertex Pharmaceuticals, an estimated $6.88M trimmed.
- Lindbrook Capital's largest Q2 2023 buy was UPAR Ultra Risk Parity ETF: 21,000 shares worth $291K.
- Lindbrook Capital added most to Vanguard Total International Stock ETF in Q2 2023, an estimated $5.37M increase.
- Lindbrook Capital's biggest Q2 2023 reduction was Vertex Pharmaceuticals, cutting an estimated $6.88M.
- Lindbrook Capital fully exited MoneyGram International, Inc. New in Q2 2023, selling an estimated $627K.
- Lindbrook Capital's ten largest holdings make up 46% of its $939M portfolio in Q2 2023.
- Lindbrook Capital opened 150 new positions and closed 215 in Q2 2023.
- Lindbrook Capital's portfolio value rose 10% quarter-over-quarter to $939M.
Based on Lindbrook Capital's 13F filing for Q2 2023, filed 31 Jul 2023.